These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1412770)

  • 1. Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients--a randomized prospective study.
    Harper SJ; Moorhouse J; Veitch PS; Bell PR; Horsburgh T; Walls J; Donnelly PK; Feehally J
    Transplantation; 1992 Oct; 54(4):742-3. PubMed ID: 1412770
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study.
    Morales JM; Rodriguez-Paternina E; Araque A; Andres A; Hernandez E; Ruilope LM; Rodicio JL
    Transplant Proc; 1994 Oct; 26(5):2598-9. PubMed ID: 7940807
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of plasminogen activator inhibitor-1 by angiotensin II receptor blockers on cyclosporine-treated renal allograft recipients.
    Ishikawa A; Ohta N; Ozono S; Kawabe K; Kitamura T
    Transplant Proc; 2005 Mar; 37(2):994-6. PubMed ID: 15848601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III trial of Rapamune versus placebo in primary renal allograft recipients.
    Ponticelli C; MacDonald AS; Rajagopalan P; Sindhi R; Mathew T
    Transplant Proc; 2001 May; 33(3):2271-2. PubMed ID: 11377525
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys.
    Jonker M; van den Hout Y; Neuhaus P; Ringers J; Kuhn EM; Bruijn JA; Schuurman HJ; Noort R; Bontrop RE; Claas FH; van Rood JJ
    Transplant Proc; 1998 Aug; 30(5):2451-3. PubMed ID: 9723534
    [No Abstract]   [Full Text] [Related]  

  • 6. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols.
    Suthanthiran M; Haschemeyer RH; Riggio RR; Adubor C; Friedman GS; Cheigh JS; Wang JC; Fotino M; Stubenbord WT; Saal SD
    Transplantation; 1993 May; 55(5):1008-13. PubMed ID: 8497873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from cyclosporine to tacrolimus in renal allograft recipients with chronic graft nephropathy: preliminary report.
    Morris-Stiff G; Baboolal K; Singh J; Balaji V; Ostrowski K; Moore R; Lord R; Jurewicz A
    Transplant Proc; 1998 Jun; 30(4):1245-6. PubMed ID: 9636506
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective randomized comparison of quadruple vs triple therapy for first cadaver transplants with immediate function.
    Johnson CP; Slakey DP; Callaluce RD; Browne BJ; Roza AM; Adams MB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):585-6. PubMed ID: 8438425
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of delayed graft function in renal transplants from cadaveric or non-heart-beating donors.
    White SA; Jain S; Absalom H; Murphy G; Williams ST; Knight A; Zickerman AM; Nicholson ML
    Transplant Proc; 2000 Feb; 32(1):189. PubMed ID: 10701018
    [No Abstract]   [Full Text] [Related]  

  • 11. The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival.
    Watson CJ; Luddington R; St John Collier DG; Calne RY; Metcalfe SM
    Transplantation; 1993 Oct; 56(4):1047-9. PubMed ID: 8212192
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged delayed graft function decreases graft survival in transplant patients taking cyclosporine.
    Fernández-Juarez G; Marcén R; Pascual J; Teruel JL; Rivera ME; Villafruela JJ; Mampaso F; Burgos FJ; Ortuño J
    Transplant Proc; 2002 Feb; 34(1):338-9. PubMed ID: 11959314
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.
    Jiang H; Fujitsu T; Sakuma S; Ogawa T; Tamura K; Fujii Y; Akiyama Y; Izumi S; Takahara S; Ishibashi M
    Transplant Proc; 1995 Feb; 27(1):367-9. PubMed ID: 7533413
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract]   [Full Text] [Related]  

  • 16. A 1-year prospective randomized study in Korean living donor kidney transplant recipients: comparing cyclosporine monotherapy and cyclosporine/prednisolone during the maintenance phase of immunosuppression.
    Park K; Kim ST; Lee SR; Koh YB; Kim HC
    Transplant Proc; 1994 Aug; 26(4):1985-6. PubMed ID: 8066642
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
    Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ
    Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
    [No Abstract]   [Full Text] [Related]  

  • 18. Trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary report.
    Henry ML; Tesi RJ; Elkhammas EA; Ferguson RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):689-90. PubMed ID: 8438438
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function.
    Liu B; Lin ZB; Ming CS; Zhang WJ; Chen ZS; Sha B; Zeng FJ; Chen S
    Transplant Proc; 2003 Feb; 35(1):87-8. PubMed ID: 12591319
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal transplantation: nifedipine for the nonstarters? A prospective randomised study.
    Donnelly PK; Feehally J; Jurewicz A; Furness P; McCullough T; Harper SJ; Moorhouse J; Morgan J; Kehinde EO; Horsburgh T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):600-1. PubMed ID: 8438431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.